Several weeks ago I had the opportunity to discuss several difficult cases with experts Drs. Paul Hesketh from the Lahey Clinic outside of Boston and Karen Kelly from Kansas University Medical Center in Kansas City, KS. These scenarios raise questions about how best to manage lung cancer issues in elderly and/or frail patients, starting with a 78 year-old woman who presented to me for discussion of the pros and cons of post-operative therapy, which also touch on other factors of administering chemotherapy to more marginal patients in general, regardless of the setting.

Here are the audio and video versions of the podcast, along with the transcript and figures.

[powerpress]

adjuvant-therapy-in-frail-and-elderly-patients-hesketh-and-kelly-audio-podcast

adjuvant-therapy-in-frail-and-elderly-patients-hesketh-and-kelly-transcript

adjuvant-therapy-in-frail-and-elderly-patients-hesketh-and-kelly-figures

This program was made possible by an educational grant from OSI Pharmaceuticals, who had no input in any of its content. We thank them for their support.

Upcoming podcasts will cover discussions of elderly/poor performance status patients with locally advanced NSCLC and metastatic lung cancer.